Fucoidan partly prevents CCl4-induced liver fibrosis

European Journal of Pharmacology

Volumn 580, Issue 3, 2008, Pages 380-384

  Hayashi, Shinji ^a   Itoh, Ayano ^a   Isoda, Katsuhiro ^a   Kondoh, Masuo ^a   Kawase, Masaya ^a   Yagi, Kiyohito ^a  

^a OSAKA UNIVERSITY   (Japan)

Author keywords

Fucoidan; Hepatic stellate cell; Hepatocyte; Liver fibrosis

Indexed keywords

ANTIFIBROTIC AGENT; CARBON TETRACHLORIDE; CYTOGLOBIN; FUCOIDIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEATH; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; LIVER CELL; LIVER CELL DAMAGE; LIVER FAILURE; LIVER FIBROSIS; LIVER PROTECTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SPRAGUE DAWLEY RAT; STELLATE CELL;

ACUTE DISEASE; ALANINE TRANSAMINASE; ALGAE, BROWN; ANIMALS; ASPARTATE AMINOTRANSFERASES; CARBON TETRACHLORIDE; CELL PROLIFERATION; CELL SURVIVAL; CHRONIC DISEASE; DOSE-RESPONSE RELATIONSHIP, DRUG; HEPATOCYTES; INJECTIONS, INTRAPERITONEAL; INJECTIONS, INTRAVENOUS; LIVER; LIVER CIRRHOSIS; MALE; POLYSACCHARIDES; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS;

EID: 38349092258     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2007.11.015     Document Type: Article

References (33)

1. Berteau O., and Mulloy B. Sulfated fucans, fresh perspectives: structures, functions, and biological properties of sulfated fucans and an overview of enzymes active toward this class of polysaccharide. Glycobiology 13 (2003) 29R-40R
2. Boisson-Vidal C., Haroun F., Ellouali M., and Blondin C. Biological activities of polysaccharides from marine algae. Drugs Future 20 (1995) 1237-1249
3. Canbay A., Higuchi H., Bronk S.F., Taniai M., Sebo T.J., and Gores G.J. Fas enhances fibrogenesis in the bile duct ligated mouse: a link between apoptosis and fibrosis. Gastroenterology 123 (2002) 1323-1330
4. Friedman S.L. Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies. N. Engl. J. Med. 328 (1993) 1828-1835
5. Friedman S.L. Evaluation of fibrosis and hepatitis C. Am. J. Med. 107 (1999) 27S-30S
6. Geerts A. History, heterogeneity, developmental biology, and functions of quiescent hepatic stellate cells. Semin. Liver Dis. 21 (2001) 311-335
7. Gressner A.M. Cytokines and cellular crosstalk involved in the activation of fat-storing cells. J. Hepatol. 22 (1995) 28-36
8. Gutierrez-Reyes G., Gutierrez-Ruiz M.C., and Kershenobich D. Liver fibrosis and chronic viral hepatitis. Arch. Med. Res. 38 (2007) 644-651
9. Haroun-Bouhedja F., Ellouali M., Sinquin C., and Boisson-Vidal C. Relationship between sulfate groups and biological activities of fucans. Thromb. Res. 100 (2000) 453-459
10. Horie T., Sakaida I., Yokoya F., Nakajo M., Sonaka I., and Okita K. l-cysteine administration prevents liver fibrosis by suppressing hepatic stellate cell proliferation and activation. Biochem. Biophys. Res. Commun. 305 (2003) 94-100
11. Houglum K., Venkataramani A., Lyche K., and Chojkier M. A pilot study of the effects of d-alpha-tocopherol on hepatic stellate cell activation in chronic hepatitis C. Gastroenterology 113 (1997) 1069-1073
12. Iredale J.P. Hepatic stellate cell behavior during resolution of liver injury. Semin. Liver Dis. 21 (2001) 427-436
13. Iredale J.P., Benyon R.C., Pickering J., McCullen M., Northrop M., Pawley S., Hovell C., and Arthur M.J. Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors. J. Clin. Invest. 102 (1998) 538-549
14. Issa R., Williams E., Trim N., Kendall T., Arthur M.J., Reichen J., Benyon R.C., and Iredale J.P. Apoptosis of hepatic stellate cells: involvement in resolution of biliary fibrosis and regulation by soluble growth factors. Gut 48 (2001) 548-557
15. Kawada N., Tran-Thi T.A., Klein H., and Decker K. The contraction of hepatic stellate (Ito) cells stimulated with vasoactive substances. Possible involvement of endothelin 1 and nitric oxide in the regulation of the sinusoidal tonus. Eur. J. Biochem. 213 (1993) 815-823
16. Kloareg B., and Quatrano R.S. Structure of the cell walls of marine algae and ecophysiological functions of the matrix polysaccharides. Oceanogr. Mar. Biol. Ann. Rev. 26 (1988) 259-315
17. Lahaye M., and Kaeffer B. Seaweed dietary fibres: structure, physico-chemical and biological properties relevant to intestinal physiology. Sci. Aliments 17 (1997) 563-584
18. Lieber C.S. Prevention and treatment of liver fibrosis based on pathogenesis. Alcohol Clin. Exp. Res. 23 (1999) 944-949
19. Mabeau S., Kloareg B., and Joseleau J.P. Fractionation and analysis of fucans from brown algae. Phytochemistry 29 (1990) 2441-2445
20. Maher J.J., and Bissell D.M. Cell-matrix interactions in liver. Semin. Cell Biol. 4 (1993) 189-201
21. Maher J.J., Saito J.M., and Neuschwander-Tetri B.A. Glutathione regulation in rat hepatic stellate cells. Comparative studies in primary culture and in liver injury in vivo. Biochem. Pharmacol. 53 (1997) 637-641
22. McCaffrey T.A., Falcone D.J., Vicente D., Du B., Consigli S., and Borth W. Protection of transforming growth factor-beta 1 activity by heparin and fucoidan. J. Cell Physiol. 159 (1994) 51-59
23. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65 (1983) 55-63
24. Nishino T., Nishioka C., Ura H., and Nagumo T. Isolation and partial characterization of a novel amino sugar-containing fucan sulfate from commercial Fucus vesiculosus fucoidan. Carbohydr. Res. 255 (1994) 213-224
25. Patel M.K., Mulloy B., Gallagher K.L., O'Brien L., and Hughes A.D. The antimitogenic action of the sulphated polysaccharide fucoidan differs from heparin in human vascular smooth muscle cells. Thromb. Haemost. 87 (2002) 149-154
26. Saito A., Yoneda M., Yokohama S., Okada M., Haneda M., and Nakamura K. Fucoidan prevents concanavalin A-induced liver injury through induction of endogenous IL-10 in mice. Hepatol. Res. 35 (2006) 190-198
27. Seglen P.O. Preparation of isolated rat liver cells. Methods Cell Biol. 13 (1976) 29-83
28. Senoo H., Imai K., Matano Y., and Sato M. Molecular mechanisms in the reversible regulation of morphology, proliferation and collagen metabolism in hepatic stellate cells by the three-dimensional structure of the extracellular matrix. J. Gastroenterol. Hepatol. 13 (1998) S19-S32
29. Song E., Lee S.K., Wang J., Ince N., Ouyang N., Min J., Chen J., Shankar P., and Lieberman J. RNA interference targeting Fas protects mice from fulminant hepatitis. Nat. Med. 9 (2003) 347-351
30. Tsukamoto H. Cytokine regulation of hepatic stellate cells in liver fibrosis. Alcohol Clin. Exp. Res. 23 (1999) 911-916
31. Weiler-Normann C., Herkel J., and Lohse A.W. Mouse models of liver fibrosis. Z Gastroenterol. 45 (2007) 43-50
32. Wu J., Kuncio G.S., and Zern M.A. Human liver growth in fibrosis and cirrhosis. In: Strain A.J., and Diehl A.M. (Eds). Liver Growth and Repair (1998), Chapman and Hall, London 558-576
33. Xue C.H., Fang Y., Lin H., Chen L., Li Z.J., Deng D., and Lu C.X. Chemical characters and antioxidative properties of sulfated polysaccharides from Laminaria japonica. J. Appl. Phycol. 13 (2001) 67-70